Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Panbela Therapeutics Inc (PBLA)

Panbela Therapeutics Inc (PBLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Panbela Therapeutics Inc 712 VISTA BLVD SUITE 305 WACONIA MN 55387 USA

www.panbela.com P: 952-479-1196

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Panbela Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in developing disruptive therapeutics for patients with urgent unmet medical needs. The company's initial product candidate, SBP-101, is for the treatment of patients with metastatic pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer. Panbela Therapeutics Inc., formerly known as Sun BioPharma Inc., is based in MINNEAPOLIS.

Key Statistics

Overview:

Market Capitalization, $K 54
Enterprise Value, $K 2,664
Shares Outstanding, K 4,855
Float, K 4,854
% Float 99.99%
Short Interest, K 0
Short Float 0.00%
Days to Cover 1.00
Short Volume Ratio 0.00
% of Insider Shareholders 0.01%
% of Institutional Shareholders 4.37%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -25,260 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,170 K
EBIT, $ -29,060 K
EBITDA, $ -29,060 K

Growth:

1-Year Return -99.74%
3-Year Return -100.00%
5-Year Return -100.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 01/01/26
Earnings Per Share ttm -71.13
EPS Growth vs. Prev Year -90.79%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 01/18/24

PBLA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity -0.23
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -3.75
Interest Coverage -78.53
60-Month Beta 1.21
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar